Silvercrest Asset Management Group LLC Acquires 12,550 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Silvercrest Asset Management Group LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 47.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 38,796 shares of the healthcare conglomerate's stock after buying an additional 12,550 shares during the period. Silvercrest Asset Management Group LLC's holdings in UnitedHealth Group were worth $19,625,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of UNH. Oak Thistle LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $563,000. Rovin Capital UT ADV boosted its position in UnitedHealth Group by 28.9% in the 4th quarter. Rovin Capital UT ADV now owns 526 shares of the healthcare conglomerate's stock valued at $266,000 after buying an additional 118 shares during the last quarter. JGP Wealth Management LLC lifted its position in UnitedHealth Group by 8.5% during the 4th quarter. JGP Wealth Management LLC now owns 911 shares of the healthcare conglomerate's stock valued at $461,000 after purchasing an additional 71 shares during the period. Capital Advisors Wealth Management LLC grew its holdings in UnitedHealth Group by 22.5% during the 4th quarter. Capital Advisors Wealth Management LLC now owns 594 shares of the healthcare conglomerate's stock worth $301,000 after acquiring an additional 109 shares during the period. Finally, Congress Park Capital LLC lifted its stake in UnitedHealth Group by 3.3% in the fourth quarter. Congress Park Capital LLC now owns 1,085 shares of the healthcare conglomerate's stock valued at $549,000 after buying an additional 35 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $23.89 during midday trading on Monday, reaching $315.80. The company's stock had a trading volume of 61,941,514 shares, compared to its average volume of 6,102,407. The stock has a market cap of $286.47 billion, a PE ratio of 20.37, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a 50-day moving average price of $470.82 and a 200-day moving average price of $513.25. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.66%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 35.18%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Truist Financial restated a "buy" rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research note on Monday. JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research report on Thursday. Robert W. Baird lowered their price objective on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Finally, TD Securities reiterated a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday. Eight equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $454.23.

Insiders Place Their Bets

In other news, Director Kristen Gil acquired 3,700 shares of the firm's stock in a transaction on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.